Clinical Trial Update: Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing self-amplifying mRNA COVID-19 vaccine LUNAR-COV19 to Comirnaty in adult hematopoietic cell transplant recipients; trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Cancer

Drugs mentioned

• Comirnaty (tozinameran)
• LUNAR-COV19

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Hematopoietic and Lymphatic System Neoplasm | Phase 2 | Status: NOT_YET_RECRUITING